Literature DB >> 20471450

FGF20 rs12720208 SNP and microRNA-433 variation: no association with Parkinson's disease in Spanish patients.

Lorena de Mena1, Lucía F Cardo, Eliecer Coto, Ana Miar, Marta Díaz, Ana I Corao, Belén Alonso, René Ribacoba, Carlos Salvador, Manuel Menéndez, Germán Morís, Victoria Alvarez.   

Abstract

DNA variation at the FGF20 gene has been associated with Parkinson's disease (PD). In particular, SNP rs12720208 in the 3' untranslated region (3' UTR) was linked to PD-risk through a mechanism that would implicate a differential binding to microRNA-433 (miR-433). The reduction of the affinity of miR-433 to the 3' UTR would result in increased FGF20 expression and upregulation of alpha-synuclein, which could in turn promote dopaminergic neurons degeneration. We genotyped the rs12720208 SNP in a total of 512 PD patients and 258 healthy controls from Spain, and searched for miR-433 variants in the patients. We did not find significant differences in allele and genotype frequencies between patients and controls. None of the patients had miR-433 variants. In conclusion, our work did not confirm the association between rs12720208 and PD, or an effect of miR-433 variants on this disease. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20471450     DOI: 10.1016/j.neulet.2010.05.019

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  21 in total

Review 1.  MicroRNAs in neurodegenerative diseases and their therapeutic potential.

Authors:  Eunsung Junn; M Maral Mouradian
Journal:  Pharmacol Ther       Date:  2011-10-08       Impact factor: 12.310

Review 2.  Epigenetic regulation in Parkinson's disease.

Authors:  Catherine Labbé; Oswaldo Lorenzo-Betancor; Owen A Ross
Journal:  Acta Neuropathol       Date:  2016-06-29       Impact factor: 17.088

Review 3.  MicroRNAs in Parkinson's disease.

Authors:  Abhishek Singh; Dwaipayan Sen
Journal:  Exp Brain Res       Date:  2017-05-19       Impact factor: 1.972

4.  MicroRNA expression patterns in human anterior cingulate and motor cortex: A study of dementia with Lewy bodies cases and controls.

Authors:  Peter T Nelson; Wang-Xia Wang; Sarah A Janse; Katherine L Thompson
Journal:  Brain Res       Date:  2017-11-13       Impact factor: 3.252

Review 5.  Nucleic Acid-Based Therapeutics for Parkinson's Disease.

Authors:  Masayuki Nakamori; Eunsung Junn; Hideki Mochizuki; M Maral Mouradian
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

Review 6.  MicroRNAs in Parkinson's disease.

Authors:  Maged M Harraz; Ted M Dawson; Valina L Dawson
Journal:  J Chem Neuroanat       Date:  2011-02-02       Impact factor: 3.052

7.  Inhibition of miR-34b and miR-34c enhances α-synuclein expression in Parkinson's disease.

Authors:  Savan Kabaria; Doo Chul Choi; Amrita Datta Chaudhuri; M Maral Mouradian; Eunsung Junn
Journal:  FEBS Lett       Date:  2014-12-23       Impact factor: 4.124

8.  Genetic analysis of FGF20 in Chinese patients with Parkinson's disease.

Authors:  Xiao-Yi Sun; Ling Wang; Lan Cheng; Nan-Nan Li; Zhong-Jiao Lu; Jun-Ying Li; Rong Peng
Journal:  Neurol Sci       Date:  2017-02-25       Impact factor: 3.307

9.  Association between FGF20 rs12720208 gene polymorphism and Parkinson's disease: a meta-analysis.

Authors:  Xianjing Zhao; Yanfeng Wu; Can Zhao; Meijiang Feng
Journal:  Neurol Sci       Date:  2016-03-29       Impact factor: 3.307

10.  Fibroblast growth factor 20 (FGF20) gene polymorphism and risk of Parkinson's disease: a meta-analysis.

Authors:  Ruixia Zhu; Ying Zhu; Xu Liu; Zhiyi He
Journal:  Neurol Sci       Date:  2014-06-19       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.